Troy Rohrbaugh, Co-CEO of the Commercial & Investment Bank, will present at the UBS Financial Services Conference in Key Biscayne, Florida on Tuesday, February 10, 2026 at 9:40 a.m. (Eastern).
A live webcast will be available on the…
Troy Rohrbaugh, Co-CEO of the Commercial & Investment Bank, will present at the UBS Financial Services Conference in Key Biscayne, Florida on Tuesday, February 10, 2026 at 9:40 a.m. (Eastern).
A live webcast will be available on the…
RARITAN, N.J., (January 14, 2026) – Johnson & Johnson (NYSE:JNJ), a worldwide leader in multiple myeloma therapies, today announced positive topline results from the investigational Phase 3 MajesTEC-9 study of…

For decades, the digital networks protecting our nation operated like a walled fortress: Once inside, you were trusted. However, in an era of sophisticated hackers, that perimeter is no longer assured.
The real-time…

Israel’s national pavilion at CES 2026 drew thousands of visitors and hosted hundreds of business meetings with investors and global companies, the Israel Export Institute said this week, as Israeli firms showcased products in areas such as AI,…

Cardiovascular diseases (CVDs) have long been a global health scourge, exacting a heavy toll on both individual well-being and health care systems worldwide. The World Health Organization (WHO) highlights that CVDs claim…

The convergence of generative artificial intelligence (AI) and health care is catalyzing a paradigm shift in clinical practice, with significant implications for the future of medicine [-]. Large language models (LLMs), exemplified by…

Traders work on the floor of the New York Stock Exchange (NYSE) in New York on January 14, 2026.
Timothy A. Clary | Afp | Getty Images
Stocks moved lower on Wednesday for a second day, pulling back further from record levels, as traders digested a…

Insider Brief

The government has defied gloomy price expectations for its latest auction for offshore wind capacity. The worry a few months ago was that bill payers would be forced to pay more than £100 a megawatt hour (MWh) via contracts that give developers…

Giredestrant, a next-generation oral selective estrogen receptor degrader (SERD) and full antagonist, significantly improved invasive disease–free survival as adjuvant treatment for patients with estrogen receptor–positive, HER2-negative…